GuideMark® Small/Mid Cap Core RS holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
GuideMark® Small/Mid Cap Core Fund RS Shares GSMRX
- NAV / 1-Day Return $23.35 / +0.41 %
- Fund Size $112.0M
- Adjusted Expense Ratio 1.930%
- Net Expense Ratio 1.830%
- Fee Level: Distribution High
- Share Class Type No Load
- Morningstar Category Small Blend
- Equity Style Box (Funds) Small Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield —
- Turnover Ratio 42%
Morningstar’s Analysis GSMRX
Will GSMRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 6.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Vanguard Extended Market ETF | 3.02 | 3M | — |
JPMorgan US Government MMkt IM | 1.09 | 1M | Cash and Equivalents |
US Foods Holding Corp | 0.38 | 378,892 | Consumer Defensive |
10x Genomics Inc Ordinary Shares - Class A | 0.35 | 347,160 | Healthcare |
F5 Inc | 0.34 | 337,511 | Technology |
APA Corp | 0.34 | 337,347 | Energy |
Exelixis Inc | 0.33 | 335,927 | Healthcare |
ATI Inc | 0.32 | 323,249 | Industrials |
Jazz Pharmaceuticals PLC | 0.32 | 322,625 | Healthcare |
Puma Biotechnology Inc | 0.31 | 316,254 | Healthcare |